2014-04-24 10:21:04 - Serbia Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on companiesandmarkets.com
While the market is small in absolute volume terms, relative per capita spending on medicines is expected to improve over the long term. As the country continues its economic convergence with developed Europe, drug consumption is also expected to rise. However, financial inefficiencies within the health insurance system mean that the National Health Insurance Institution (RZZO) is unable to always meet its obligations on time, leaving patients to pay for formerly reimbursed medicines or hospitals having to cover the difference.
Headline Expenditure Projections
- Pharmaceuticals: RSD81.38bn (US$0.93bn) in 2012 to RSD91.16bn (US$1.10bn) in 2013; +12.0% in local currency terms and +19.1% in US dollar terms.
- Healthcare: RSD358.07bn (US$4.07bn) in 2012 to RSD383.88bn (US$4.64bn) in 2013; +7.2% in local currency terms and +14.0%
in US dollar terms.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.